These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25708446)

  • 1. Association of colonic regulatory T cells with hepatitis C virus pathogenesis and liver pathology.
    Hetta HF; Mekky MA; Khalil NK; Mohamed WA; El-Feky MA; Ahmed SH; Daef EA; Nassar MI; Medhat A; Sherman KE; Shata MT
    J Gastroenterol Hepatol; 2015 Oct; 30(10):1543-51. PubMed ID: 25708446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesis.
    Sturm N; Thélu MA; Camous X; Dimitrov G; Ramzan M; Dufeu-Duchesne T; Bonorino P; Guillermet C; Brambilla E; Arvers P; Pernollet M; Leroy V; Zarski JP; Marche PN; Jouvin-Marche E
    J Hepatol; 2010 Jul; 53(1):25-35. PubMed ID: 20452085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extra-hepatic infection of hepatitis C virus in the colon tissue and its relationship with hepatitis C virus pathogenesis.
    Hetta HF; Mekky MA; Khalil NK; Mohamed WA; El-Feky MA; Ahmed SH; Daef EA; Medhat A; Nassar MI; Sherman KE; Shata MTM
    J Med Microbiol; 2016 Aug; 65(8):703-712. PubMed ID: 27166142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis.
    Claassen MA; de Knegt RJ; Tilanus HW; Janssen HL; Boonstra A
    J Hepatol; 2010 Mar; 52(3):315-21. PubMed ID: 20129690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of FOXP3+ Regulatory T-cells in the Blood of Chronic Hepatitis C Patients with Immune Mediated Skin Manifestations; Relationship to Hepatic Condition and Viral Load.
    Farid C; Sheikh WE; Swelem R; El-Ghitany E
    Clin Lab; 2016 Dec; 62(12):2339-2348. PubMed ID: 28164561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection.
    Riezu-Boj JI; Larrea E; Aldabe R; Guembe L; Casares N; Galeano E; Echeverria I; Sarobe P; Herrero I; Sangro B; Prieto J; Lasarte JJ
    J Hepatol; 2011 Mar; 54(3):422-31. PubMed ID: 21129807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Core-specific adaptive regulatory T-cells in different outcomes of hepatitis C.
    Langhans B; Braunschweiger I; Arndt S; Schulte W; Satoguina J; Layland LE; Vidovic N; Hoerauf A; Oldenburg J; Sauerbruch T; Spengler U
    Clin Sci (Lond); 2010 Apr; 119(2):97-109. PubMed ID: 20222873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral blood and hepatic Toll-like receptor 7 expression and interferon lambda 1 levels in chronic hepatitis C: Relation to virus replication and liver injury.
    El Aggan H; Farahat N; El Deeb N; Zeid A; El-Shendidi A
    Microb Pathog; 2019 Jun; 131():65-74. PubMed ID: 30926417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic IL-8 producing Foxp3⁺CD4⁺ regulatory T cells and fibrogenesis in chronic hepatitis C.
    Langhans B; Krämer B; Louis M; Nischalke HD; Hüneburg R; Staratschek-Jox A; Odenthal M; Manekeller S; Schepke M; Kalff J; Fischer HP; Schultze JL; Spengler U
    J Hepatol; 2013 Aug; 59(2):229-35. PubMed ID: 23624000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced ability of regulatory T cells in chronic hepatitis C patients with persistently normal alanine aminotransferase levels than those with active hepatitis.
    Itose I; Kanto T; Kakita N; Takebe S; Inoue M; Higashitani K; Miyazaki M; Miyatake H; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    J Viral Hepat; 2009 Dec; 16(12):844-52. PubMed ID: 19486278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imbalance of regulatory T cells and T helper type 17 cells in patients with chronic hepatitis C.
    Hao C; Zhou Y; He Y; Fan C; Sun L; Wei X; Wang L; Peng M; Wang P; Lian J; Jia Z
    Immunology; 2014 Dec; 143(4):531-8. PubMed ID: 24903732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic hepatitis C liver microenvironment: role of the Th17/Treg interplay related to fibrogenesis.
    Rios DA; Valva P; Casciato PC; Frias S; Soledad Caldirola M; Gaillard MI; Bezrodnik L; Bandi J; Galdame O; Ameigeiras B; Krasniansky D; Brodersen C; Mullen E; Matteo EN; Preciado MV
    Sci Rep; 2017 Oct; 7(1):13283. PubMed ID: 29038590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normocaloric low cholesterol diet modulates Th17/Treg balance in patients with chronic hepatitis C virus infection.
    Maggio R; Viscomi C; Andreozzi P; D'Ettorre G; Viscogliosi G; Barbaro B; Gori M; Vullo V; Balsano C
    PLoS One; 2014; 9(12):e112346. PubMed ID: 25532016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Schistosoma mansoni co-infection on serum profile of interferon-gamma, interleukin-4 and interleukin-10 in patients with chronic hepatitis C virus infection.
    Emam EA; Emam M; Shehata AE; Emara M
    Egypt J Immunol; 2006; 13(2):33-40. PubMed ID: 18689269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Treg and TH17 Cytokines with HCV Pathogenesis and Liver Pathology.
    Elkhawaga AA; Hosni A; Zaky DZ; Kamel AA; Mohamed NA; Abozaid MA; El-Masry MA
    Egypt J Immunol; 2019 Jul; 26(2):55-63. PubMed ID: 31926495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased CD4+CD25+ regulatory T cells correlate with poor short-term outcomes in hepatitis B virus-related acute-on-chronic liver failure patients.
    Shen C; Yan WZ; Zhao CY; Che HH; Liu XY; Liu ZZ; Wang YD; Wang W; Li M; Gao J
    J Microbiol Immunol Infect; 2015 Apr; 48(2):137-46. PubMed ID: 24388581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].
    Delhem N; Cottrez F; Carpentier A; Miroux C; Moralès O; François V; Groux H; Auriault C; Pancré V
    Bull Cancer; 2008 Nov; 95(11):1029-38. PubMed ID: 19036674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between regulatory T cells and the combination of pegylated interferon and ribavirin for the treatment of chronic hepatitis type C.
    Akiyama M; Ichikawa T; Miyaaki H; Motoyoshi Y; Takeshita S; Ozawa E; Miuma S; Shibata H; Taura N; Nakao K
    Intervirology; 2010; 53(3):154-60. PubMed ID: 20068349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced high-mobility group box 1 (HMGB1) modulates regulatory T cells (Treg)/T helper 17 (Th17) balance via toll-like receptor (TLR)-4-interleukin (IL)-6 pathway in patients with chronic hepatitis B.
    Li J; Wang FP; She WM; Yang CQ; Li L; Tu CT; Wang JY; Jiang W
    J Viral Hepat; 2014 Feb; 21(2):129-40. PubMed ID: 24383926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine levels and histopathology in chronic hepatitis B and chronic hepatitis C.
    Akcam FZ; Tigli A; Kaya O; Ciris M; Vural H
    J Interferon Cytokine Res; 2012 Dec; 32(12):570-4. PubMed ID: 23067363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.